维普中文期刊产品整合服务
125篇 您的检索式:作者名="Maguchi"
    题名 作者 年代 出处 被引量
1胆道肿瘤临床实践指南(英文第三版)显示文摘日本肝胆胰外科学会(JSHBPS)于2007年出版第一版胆道肿瘤(胆管癌、胆囊癌及壶腹癌)临床实践指南,于2014年更新第二版,2021年英文第三版胆道肿瘤临床实践指南围绕6个主题提出若干临床问题,基于相关循证医学证据并组织专家讨论后,最终确定推荐意见、推荐强度以及推荐说明。根据证据推荐分级的评估、制订与评价(GRADE)系统,推荐强度被分为1级(强)或者2级(弱)。英文第三版胆道肿瘤临床实践指南中提出的31个临床问题涵盖:(1)预防性治疗;(2)诊断;(3)胆道引流;(4)外科治疗;(5)化疗;(6)放疗。31个临床问题中,14个问题给予推荐强度为强的推荐意见,14个问题给予推荐强度为弱的推荐意见,剩余的3个问题未给予推荐意见。每条推荐意见都进行推荐强度说明。最新版指南基于循证医学证据,为临床提供了重要建议。未来与癌症登记数据库协作将是评估指南和建立新证据的关键。Masato Nagino Satoshi Hirano Hideyuki Yoshitomi Taku Aoki Katsuhiko Uesaka Michiaki Unno Tomoki Ebata Masaru Konishi Keiji Sano Kazuaki Shimada Hiroaki Shimizu Ryota Higuchi Toshifumi Wakai Hiroyuki Isayama Takuji Okusaka Toshio Tsuyuguchi Yoshiki Hirooka Junji Furuse Hiroyuki Maguchi Kojiro Suzuki Hideya Yamazaki Hiroshi Kijima Akio Yanagisawa Masahiro Yoshida Yukihiro Yokoyama Takashi Mizuno Itaru Endo 杨翼飞(译) 仇毓东(译) 赵梦珂(译) 伏旭(译) 蔡正华(译) 毛凉(审校) 2021中华消化外科杂志2021,20,4:7
2MicroRNA-31 expression in colorectal serrated pathway progression显示文摘MicroRNAs have been increasingly recognized as useful biomarkers for colorectal cancers(CRC).We have recently observed that microRNA-31(miR-31)expression is associated with BRAF mutation and prognosis in CRC.Moreover,high miR-31 expression is frequently detected in sessile serrated adenomas compared with hyperplastic polyps(HPs).These results suggest that miR-31 may contribute to the progression of serrated lesions.At a follow-up colonoscopy,we observed the case of a 75-year-old man with a 7-mm flat-elevated lesion in the cecum and diagnosed the lesion as an early invasive carcinoma with serrated features.Tissue specimens were obtained from the representative areas to compare the molecular alterations in the carcinoma component with those in the HP component.Higher miR-31 expression was observed in the carcinoma component(57-fold increase)and the HP component(8-fold increase)compared with the paired normal mucosa,suggesting that miR-31 may be one of the key molecules in serrated pathway progression.Hironori Aoki Katsuhiko Nosho Hisayoshi Igarashi Miki Ito Kei Mitsuhashi Takafumi Naito Eiichiro Yamamoto Tokuma Tanuma Masafumi Nomura Hiroyuki Maguchi Toshiya Shinohara Hiromu Suzuki Hiroyuki Yamamoto Yasuhisa Shinomura 2014World Journal of Gastroenterology2014,20,34:5
3Familial pancreatic cancer: Concept, management and issues显示文摘Familial pancreatic cancer (FPC) is broadly defined as two first-degree-relatives with pancreatic cancer (PC) and accounts for 4%-10% of PC. Several genetic syndromes, including Peutz-Jeghers syndrome, hereditary pancreatitis, hereditary breast-ovarian cancer syndrome(HBOC), Lynch syndrome, and familial adenomatous polyposis (FAP), also have increased risks of PC, but the narrowest definition of FPC excludes these known syndromes. When compared with other familial tumors, proven genetic alterations are limited to a small proportion (<20%) and the familial aggregation is usually modest. However, an ethnic deviation (Ashkenazi Jewish>Caucasian) and a younger onset are common also in FPC. In European countries, 'anticipation' is reported in FPC families, as with other hereditary syndromes; a trend toward younger age and worse prognosis is recognized in the late years. The resected pancreases of FPC kindred often show multiple pancreatic intraepithelial neoplasia (Pan IN) foci, with various K-ras mutations, similar to colorectal polyposis seen in the FAP patients. As with HBOC patients, a patient who is a BRCA mutation carrier with unresectable pancreatic cancer (accounting for 0%-19% of FPC patients) demonstrated better outcome following platinum and Poly (ADP-ribose) polymerase inhibitor treatment. Western countries have established FPC registries since the 1990 s and several surveillance projects for highrisk individuals are now ongoing to detect early PCs. Improvement in lifestyle habits, including non-smoking, is recommended for individuals at risk. In Japan, the FPC study group was initiated in 2013 and the Japanese FPC registry was established in 2014 by the Japan Pancreas Society.Hiroyuki Matsubayashi Kyoichi Takaori Chigusa Morizane Hiroyuki Maguchi Masamichi Mizuma Hideaki Takahashi Keita Wada Hiroko Hosoi Shinichi Yachida Masami Suzuki Risa Usui Toru Furukawa Junji Furuse Takamitsu Sato Makoto Ueno Yoshimi Kiyozumi Susumu Hijioka Nobumasa Mizuno Takeshi Terashima Masaki Mizumoto Yuzo Kodama Masako Torishima Takahisa Kawaguchi Reiko Ashida Masayuki Kitano Keiji Hanada Masayuki Furukawa Ken Kawabe Yoshiyuki Majima Toru Shimosegawa 2017World Journal of Gastroenterology2017,23,6:5
4Large balloon dilation for the treatment of recurrent bile duct stones prevents short-term recurrence in patients with previous endoscopic sphincterotomy显示文摘Ryo Harada Hiroyuki Maguchi Kuniyuki Takahashi Akio Katanuma Manabu Osanai Kei Yane Syunpei Hashigo Maki Kaneko Ryusuke Katoh Shin Katoh 2013Journal of Hepato-Biliary-Pancreatic Sciences2013,,5:3
5Resected tumor seeding in stomach wall due to endoscopic ultrasonography-guided fine needle aspiration of pancreatic adenocarcinoma显示文摘Endoscopic ultrasonography-guided fine needle aspiration(EUS-FNA) is a useful and relatively safe tool for the diagnosis and staging of pancreatic cancer. However, there have recently been several reports of tumor seeding after EUS-FNA of adenocarcinomas. A 78-year-old man was admitted to our hospital due to upper gastric pain. Examinations revealed a 20 mm mass in the pancreatic body, for which EUS-FNA was performed. The cytology of the lesion was adenocarcinoma, and the stage of the cancer was T3N0M0. The patient underwent surgery with curative intent, followed by adjuvant chemotherapy with S-1. An enlarging gastric submucosal tumor was found on gastroscopy at 28 mo after surgery accompanied by a rising level of CA19-9. Biopsy result was adenocarcinoma, consistent with a pancreatic primary tumor. Tumor seeding after EUS-FNA was strongly suspected. The patient underwent surgical resection of the gastric tumor with curative intent. The pathological result of the resected gastric specimen was adenocarcinoma with a perfectly matched mucin special stain result with the previously resected pancreatic cancer. This is the first case report of tumor seeding after EUS-FNA which was surgically resected and inspected pathologically.Akiko Tomonari Akio Katanuma Tomoaki Matsumori Hajime Yamazaki Itsuki Sano Ryuki Minami Manabu Sen-yo Satoshi Ikarashi Toshifumi Kin Kei Yane Kuniyuki Takahashi Toshiya Shinohara Hiroyuki Maguchi 2015World Journal of Gastroenterology2015,21,27:3
6Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones显示文摘Ichiro Yasuda Naotaka Fujita Hiroyuki Maguchi Osamu Hasebe Yoshinori Igarashi Akihiko Murakami Hidekazu Mukai Tsuneshi Fujii Kenji Yamao Kensei Maeshiro Tomoko Tada Takeshi Tsujino Yutaka Komatsu 2010Gastrointestinal Endoscopy2010,,6:2
7Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial显示文摘Naotaka Fujita Hiroyuki Maguchi Yutaka Komatsu Ichiro Yasuda Osamu Hasebe Yoshinori Igarashi Akihiko Murakami Hidekazu Mukai Tsuneshi Fujii Kenji Yamao Kensei Maeshiro 2003Gastrointestinal Endoscopy2003,,2:2
8Thickened inner hypoechoic layer of the gallbladder wall in the diagnosis of anomalous pancreaticobiliary ductal union with endosonography显示文摘Tanno S Obara T Maguchi H 1997Gastrointest Endosc1997,46,6:1
9Autonmic nervous function in non dipper essential hypertensive subjects:evaluation by power spectral analysis of heart rale variability显示文摘Kohara K Nishida W Maguchi M 1995Hypertension1995,26,5:1
10Endoscopic sphinctero- tomy and endoscopic papillary balloon dilatation for bile duct stones: A prospective randomized controlled multicenter trial 显示文摘Fujita N Maguchi H Komatsu Y 2003Gastrointest Endosc2003,57,2:1
11Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial显示文摘Fujita N Maguchi H Komatsu Y Yasuda I Hasebe O Igarashi Y JESED Study Group 2003Gastrointest Endosc2003,57,:1
12Endoscopic sphinc- terotomy and endoscopic papillary balloon dilation for bile duct stones:A Prospective randomized controlled muhieenter trial显示文摘Fujita N Maguchi H Komatsu Y 2003Gastrointest Endosc2003,57,:1
13In vivo expression of IL-4,IL-5,IL-13 and IFN-mRNAs in peripheral blood mononuclear cells and effects of cyclospfin A in a patient with Kimura's disease显示文摘 Itami S Maguchi T 1997Br J Dermatol1997,137,6:1
14Long-term outcomes after en- doscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones 显示文摘Yasuda I Fujita N Maguchi H 2010Gastrointestinal Endoscopy2010,72,6:1
15Endoscopic management of la-paroscopic cholecystectomy-associated bile duct injuries显示文摘Ichiya T Maguchi H Takahashi K 2011J Hepatobil-iary Panreat Sci2011,18,1:1
16Thickened inner hypoechoic layer of the gallbladder wall in the diagnosis of anomalous pancreaticobiliary ductal union with endosonography显示文摘Satoshi Tanno Takeshi Obara Hiroyuki Maguchi Yusuke Mizukami Ryushi Shudo Tsuneshi Fujii Kuniyuki Takahashi Noriyuki Nishino Satoshi Arisato Yusuke Saitoh Hitoshi Ura Yutaka Kohgo 1997Gastrointestinal Endoscopy1997,,:1
17Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones:A prospective randomized controlled multicenter trial显示文摘Fujita N Maguchi H Komatsu Y 2003Gastrointest Endosc2003,57,2:1
18Adsorptive separation of arsenate and arsenite anions from aqueous medium by using orange waste显示文摘GHIMIRE K N INOUE K HIROKI YA- MAGUCHI Water Rearch0,37,20:1
19Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent 显示文摘Sofuni A Maguchi H Itoi T 2007Clin Gastroenterol Hepatol2007,5,11:1
20Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for dile duct stones:a prospective randomized controlled multicenter trial显示文摘Fujita N Maguchi H Komatsu Y 2003Gastrointest Endosc2003,57,2:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费